Latest News

Medicare Now Covers Genetic Tests for Targeting Depression Drugs

An oral swab test that gives doctors an easy-to-read report to help guide decisions about prescribing depression medications is now available to 50 million Americans on Medicare. The test is GeneSight Psychotropic and is made by Assurex Health of Mason, Ohio. The Centers for Medicare and Medicaid Services (CMS), the nation’s largest healthcare payer, last month agreed to begin paying for the test for seniors who have tried at least one depression medication without success….Read More

 

Notice: The “Read more…” link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc. or socialsecurityreport.org.

What's Your Opinion?

We welcome your comments. Join the discussion and let your voice be heard. All fields are required

Website by Geiger Computers